Jimenez Freddy A. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Jimenez Freddy A.
SVP & GENERAL COUNSEL
Transactions
- Exercise/Conversion
Common Stock
2024-06-05$10.38/sh+9,540$99,025→ 35,464 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-05−9,540→ 18,454 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (9,540 underlying)
Footnotes (1)
- [F1]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.